Clinical Trial

Evolve China PMCF Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multi-center, single-arm, open-label, observational, post-market clinical follow-up. The expected duration of the study is 8 years (including up to 5-years' follow-up). Each subject will be followed up per standard of care (SoC) at each study site.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-04-11; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2026-03-25
Status change: Not Yet Recruiting → Recruiting 2024-10-23
Trial Details
NCT Number NCT06368622
Lead Sponsor Stryker Neurovascular
Collaborators: Stryker (Beijing) Healthcare Products Co., Ltd
Conditions Intracranial Aneurysm
Enrollment 500 participants
Start Date 2024-04-24
Primary Completion 2027-11 (estimated)
Study Completion 2031-08 (estimated)
Updated on ClinicalTrials.gov 2026-03-30